Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Kaori Sano, Akira Ainai, Tadaki Suzuki & Hideki Hasegawa. (2018) Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics. Expert Review of Vaccines 17:8, pages 687-696.
Read now
Read now
Amandine Gagneux-Brunon, Frédéric Lucht, Odile Launay, Philippe Berthelot & Elisabeth Botelho-Nevers. (2018) Vaccines for healthcare-associated infections: present, future, and expectations. Expert Review of Vaccines 17:5, pages 421-433.
Read now
Read now
Yunfeng Long, Lei Ma, Ze Liu, Shaohui Song, Xingliang Geng, Fan Yang, Qi Guo, Zhuofan Li, Weidong Li & Guoyang Liao. (2018) Preparation and evaluation of a novel, live, attenuated influenza H1N1 vaccine strain produced by a modified classical reassortment method. Human Vaccines & Immunotherapeutics 14:3, pages 615-622.
Read now
Read now
Sai V Vemula, Ekramy E Sayedahmed, Suryaprakash Sambhara & Suresh K Mittal. (2017) Vaccine approaches conferring cross-protection against influenza viruses. Expert Review of Vaccines 16:11, pages 1141-1154.
Read now
Read now
Yafang Huang, Huili Wang & Wilson W.S. Tam. (2017) Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis. Current Medical Research and Opinion 33:10, pages 1901-1908.
Read now
Read now
Jeffrey B Ulmer, Monique K Mansoura & Andrew J Geall. (2015) Vaccines ‘on demand’: science fiction or a future reality. Expert Opinion on Drug Discovery 10:2, pages 101-106.
Read now
Read now
Cécile van Els, Siri Mjaaland, Lisbeth Næss, Julia Sarkadi, Eva Gonczol, Karen Smith Korsholm, Jon Hansen, Jørgen de Jonge, Gideon Kersten, Jennifer Warner, Amanda Semper, Corine Kruiswijk & Fredrik Oftung. (2014) Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Human Vaccines & Immunotherapeutics 10:7, pages 1935-1948.
Read now
Read now
Diego Esteban Cargnelutti, María Victoria Sánchez, Nora Marta Mattion & Eduardo Alberto Scodeller. (2013) Development of a universal CTL-based vaccine for influenza. Bioengineered 4:6, pages 374-378.
Read now
Read now
Armin Hekele, Sylvie Bertholet, Jacob Archer, Daniel G Gibson, Giuseppe Palladino, Luis A Brito, Gillis R Otten, Michela Brazzoli, Scilla Buccato, Alessandra Bonci, Daniele Casini, Domenico Maione, Zhi-Qing Qi, John E Gill, Nicky C Caiazza, Jun Urano, Bolyn Hubby, George F Gao, Yuelong Shu, Ennio De Gregorio, Christian W Mandl, Peter W Mason, Ethan C Settembre, Jeffrey B Ulmer, J Craig Venter, Philip R Dormitzer, Rino Rappuoli & Andrew J Geall. (2013) Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice. Emerging Microbes & Infections 2:1, pages 1-7.
Read now
Read now
Ali Rowhani-Rahbar, Nicola P Klein & Roger Baxter. (2012) Assessing the safety of influenza vaccination in specific populations: children and the elderly. Expert Review of Vaccines 11:8, pages 973-984.
Read now
Read now
Articles from other publishers (36)
Cindy Hörner, Anna H. Fiedler, Bianca S. Bodmer, Lisa Walz, Vivian A. Scheuplein, Stefan Hutzler, Mikhail N. Matrosovich, Veronika von Messling & Michael D. Mühlebach. (2023) A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9. npj Vaccines 8:1.
Crossref
Crossref
Silvia Minozzi, Theodore Lytras, Silvia Gianola, Marien Gonzalez-Lorenzo, Greta Castellini, Cristina Galli, Danilo Cereda, Stefanos Bonovas, Elena Pariani & Lorenzo Moja. (2022) Comparative efficacy and safety of vaccines to prevent seasonal influenza: A systematic review and network meta-analysis. eClinicalMedicine 46, pages 101331.
Crossref
Crossref
Yuchong Wang, Xujun Zhang, Kefan Bi & Hongyan Diao. (2021) Critical role of microRNAs in host and influenza A (H1N1) virus interactions. Life Sciences 277, pages 119484.
Crossref
Crossref
Jeffrey W. Ecker, Greg A. Kirchenbaum, Spencer R. Pierce, Amanda L. Skarlupka, Rodrigo B. Abreu, R. Ethan Cooper, Dawn Taylor-Mulneix, Ted M. Ross & Giuseppe A. Sautto. (2020) High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines. Vaccines 8:3, pages 462.
Crossref
Crossref
Jaspreet Singh Kochhar, Justin J. Y. Tan, Yee Chin Kwang & Lifeng KangJaspreet Singh Kochhar, Justin J. Y. Tan, Yee Chin Kwang & Lifeng Kang. 2019. Microneedles for Transdermal Drug Delivery. Microneedles for Transdermal Drug Delivery
95
144
.
Wenxiu Wang, Abdelrahman Said, Baoqin Wang, Guanggang Qu, Qingqing Xu, Bo Liu & Zhiqiang Shen. (2018) Establishment and evaluation of the goose embryo epithelial (GEE) cell line as a new model for propagation of avian viruses. PLOS ONE 13:3, pages e0193876.
Crossref
Crossref
Kris M. White, Juan Ayllon, Ignacio Mena, Anna Potenski, Florian Krammer & Adolfo García-Sastre. (2018) Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation. Vaccine 36:9, pages 1146-1153.
Crossref
Crossref
Irshad A. Hajam, Pervaiz A. Dar, Gayeon Won & John Hwa Lee. (2017) Bacterial ghosts as adjuvants: mechanisms and potential. Veterinary Research 48:1.
Crossref
Crossref
Anuradha Madan, Harry Collins, Eric Sheldon, Louise Frenette, Laurence Chu, Damien Friel, Mamadou Drame, David W. Vaughn, Bruce L. Innis & Anne Schuind. (2017) Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial. Vaccine 35:35, pages 4621-4628.
Crossref
Crossref
Ernest Milián, Thomas Julien, Rafael Biaggio, Alina Venereo-Sanchez, Johnny Montes, Aziza P. Manceur, Sven Ansorge, Emma Petiot, Manuel Rosa-Calatrava & Amine Kamen. (2017) Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics. Vaccine 35:26, pages 3423-3430.
Crossref
Crossref
Dongying Du, Pantao Zhang, Xiangdong Li, Hui Tian, Yi Cheng, Dongbei Sheng, Xueying Han, Yihong Shan, Xuefeng Li, Yue Yuan, Haiyang Zhang, Jingjing Xue, Wujie Liu & Kegong Tian. (2017) Cell-culture derived fowl adenovirus serotype 4 inactivated vaccine provides complete protection for virus infection on SPF chickens. VirusDisease 28:2, pages 182-188.
Crossref
Crossref
Yanmei Ma, Jing Ouyang, Jingyun Wei, Mohamed Maarouf & Ji-Long Chen. (2016) Involvement of Host Non-Coding RNAs in the Pathogenesis of the Influenza Virus. International Journal of Molecular Sciences 18:1, pages 39.
Crossref
Crossref
Muhammad Asif Zahoor, Mohsin Khurshid, Rabia Qureshi, Aneeqa Naz & Muhammad Shahid. (2016) Cell culture-based viral vaccines: current status and future prospects. Future Virology 11:7, pages 549-562.
Crossref
Crossref
Yafang Huang, Huili Wang, Ling Wan, Xiaoqin Lu & Wilson W.S. Tam. (2016) Is Systemic Lupus Erythematosus Associated With a Declined Immunogenicity and Poor Safety of Influenza Vaccination?. Medicine 95:19, pages e3637.
Crossref
Crossref
Kyuri KangSeunghoon HanTaegon HongSangil JeonJeongki PaekJin Han KangDong-Seok Yim. (2016) Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial. Yonsei Medical Journal 57:6, pages 1354.
Crossref
Crossref
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
259
291
.
Neal A. Halsey, Kawsar R. Talaat, Adena Greenbaum, Eric Mensah, Matthew Z. Dudley, Tina Proveaux & Daniel A. Salmon. (2015) The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper. Vaccine 33, pages F1-F67.
Crossref
Crossref
Xiaolan Yang, Jianyu Zhao, Cheng Wang, Yueqiang Duan, Zhongpeng Zhao, Rui Chen, Liangyan Zhang, Li Xing, Chengcai Lai, Shaogeng Zhang, Xiliang Wang & Penghui Yang. (2015) Immunization with a Live Attenuated H7N9 Influenza Vaccine Protects Mice against Lethal Challenge. PLOS ONE 10:4, pages e0123659.
Crossref
Crossref
Xiaoyue Shen, Wenkui Sun, Yi Shi, Zheng Xing & Xin Su. (2015) Altered Viral Replication and Cell Responses by Inserting MicroRNA Recognition Element into PB1 in Pandemic Influenza A Virus (H1N1) 2009. Mediators of Inflammation 2015, pages 1-12.
Crossref
Crossref
Ernest Milián & Amine A. Kamen. (2015) Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
Pierre-Alain Moisset, Jeffrey Pederson & Nathalie Landry. 2015. Vaccine Analysis: Strategies, Principles, and Control. Vaccine Analysis: Strategies, Principles, and Control
113
137
.
Corinne Pion, Virginie Courtois, Stéphanie Husson, Marie-Clotilde Bernard, Marie-Claire Nicolai, Philippe Talaga, Emanuelle Trannoy, Catherine Moste, Régis Sodoyer & Isabelle Legastelois. (2014) Characterization and immunogenicity in mice of recombinant influenza haemagglutinins produced in Leishmania tarentolae. Vaccine 32:43, pages 5570-5576.
Crossref
Crossref
Anne N. Nafziger & David S. Pratt. (2014) Seasonal influenza vaccination and technologies. The Journal of Clinical Pharmacology 54:7, pages 719-731.
Crossref
Crossref
Teddy Wohlbold & Florian Krammer. (2014) In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen. Viruses 6:6, pages 2465-2494.
Crossref
Crossref
Yueqiang Duan, Hongjing Gu, Rui Chen, Zhongpeng Zhao, Liangyan Zhang, Li Xing, Chengcai Lai, Peirui Zhang, Zhiwei Li, Keming Zhang, Zhouhai Wang, Shaogeng Zhang, Xiliang Wang & Penghui Yang. (2014) Response of Mice and Ferrets to a Monovalent Influenza A (H7N9) Split Vaccine. PLoS ONE 9:6, pages e99322.
Crossref
Crossref
Elke Bergmann-Leitner & Wolfgang Leitner. (2014) Adjuvants in the Driver’s Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators. Vaccines 2:2, pages 252-296.
Crossref
Crossref
Markus Hilleringmann, Björn Jobst & Barbara C. Baudner. 2014. Molecular Vaccines. Molecular Vaccines
823
837
.
Giuseppe Del Giudice & Rino Rappuoli. 2015. Influenza Pathogenesis and Control - Volume II. Influenza Pathogenesis and Control - Volume II
151
180
.
Philip R. Dormitzer. 2015. Influenza Pathogenesis and Control - Volume II. Influenza Pathogenesis and Control - Volume II
237
273
.
S. Kommareddy, B.C. Baudner, A. Bonificio, S. Gallorini, G. Palladino, A.S. Determan, D.M. Dohmeier, K.D. Kroells, J.R. Sternjohn, M. Singh, P.R. Dormitzer, K.J. Hansen & D.T. O’Hagan. (2013) Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine 31:34, pages 3435-3441.
Crossref
Crossref
Mustafeez Mujtaba Babar, Muhammad Suleman Riaz, Najam-us-Sahar Sadaf Zaidi, Farhan Afzal & Muhammad Sabir Farooq. (2013) Production of avian influenza virus vaccine using primary cell cultures generated from host organs. Journal of Industrial Microbiology and Biotechnology 40:6, pages 625-632.
Crossref
Crossref
Philip R. DormitzerPirada SuphaphiphatDaniel G. GibsonDavid E. WentworthTimothy B. StockwellMikkel A. AlgireNina AlperovichMario BarroDavid M. BrownStewart CraigBrian M. DattiloEvgeniya A. DenisovaIvna De SouzaMarkus EickmannVivien G. DuganAnnette FerrariRaul C. GomilaLiqun HanCasey JudgeSarthak ManeMikhail MatrosovichChuck MerrymanGiuseppe PalladinoGene A. PalmerTerika SpencerThomas StreckerHeidi TrusheimJennifer UhlendorffYingxia WenAnthony C. YeeJayshree ZaveriBin ZhouStephan BeckerArmen DonabedianPeter W. MasonJohn I. GlassRino RappuoliJ. Craig Venter. (2013) Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics. Science Translational Medicine 5:185.
Crossref
Crossref
Dustin P. Patterson, Agnieszka Rynda-Apple, Ann L. Harmsen, Allen G. Harmsen & Trevor Douglas. (2013) Biomimetic Antigenic Nanoparticles Elicit Controlled Protective Immune Response to Influenza. ACS Nano 7:4, pages 3036-3044.
Crossref
Crossref
Sushma Kommareddy, Amanda Bonificio, Simona Gallorini, Barbara Baudner, Manmohan Singh & Derek O'hagan. (2013) Preparation of Highly Concentrated Influenza Vaccine for Use in Novel Delivery Approaches. Journal of Pharmaceutical Sciences 102:3, pages 866-875.
Crossref
Crossref
Ji Yun NohWoo Joo Kim. (2013) Influenza Vaccines: Unmet Needs and Recent Developments. Infection & Chemotherapy 45:4, pages 375.
Crossref
Crossref
Silvia Minozzi, Theodore Lytras, Silvia Gianola, Marien Gonzalez-Lorenzo, Greta Castellini, Cristina Galli, Danilo Cereda, Stefanos Bonovas & Elena Pariani. (2021) Comparative Efficacy and Safety of Vaccines to Prevent Seasonal Influenza: A Systematic Review and Network Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref